Entity
Description
  • Value proposition

    Transpara - Smart AI for early breast cancer detection.
    Confidence. Workflow. Results.
    Try the ScreenPoint Experience!

    ScreenPoint helps radiologists detect breast cancer confidently and faster. We develop and market image analysis and machine learning applications and services to improve early detection of breast cancer. Our flagship product - Transpara - has been evaluated in over 35+ peer-reviewed publications and has demonstrated consistent results, regardless of patient age, breast density, or ethnicity. Transpara uses the latest developments in machine learning such as Deep Learning and is trained with very large well curated databases of screening mammograms. Research and development at ScreenPoint is aimed at improving performance to the level of expert radiologists and beyond.

    Computer-aided detection (CAD), Medical Imaging, Decision support, Deep Learning, Breast cancer, Mammography, and Screening

  • Transpara Breast AI by ScreenPoint Medical

    Transpara Breast AI by ScreenPoint Medical brings you better workflow and greater confidence when reading mammograms. Learn more here.

  • https://screenpoint-medical.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Bayer
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Other

21 Mar 2024


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

17 Oct 2020


Similar entities
Loading...
Loading...
Social network dynamics